OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours
Claire Adams, Emanuela Ercolano, Sara Ferluga, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1273-1273
Open Access | Times Cited: 15
Claire Adams, Emanuela Ercolano, Sara Ferluga, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1273-1273
Open Access | Times Cited: 15
Showing 15 citing articles:
Multifaceted microglia — key players in primary brain tumour heterogeneity
Lily Keane, Mathilde Cheray, Klas Blomgren, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 4, pp. 243-259
Closed Access | Times Cited: 41
Lily Keane, Mathilde Cheray, Klas Blomgren, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 4, pp. 243-259
Closed Access | Times Cited: 41
Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma
Liyam Laraba, Lily Hillson, Julio Grimm de Guibert, et al.
Brain (2022) Vol. 146, Iss. 4, pp. 1697-1713
Open Access | Times Cited: 36
Liyam Laraba, Lily Hillson, Julio Grimm de Guibert, et al.
Brain (2022) Vol. 146, Iss. 4, pp. 1697-1713
Open Access | Times Cited: 36
Basis for Immunotherapy for Treatment of Meningiomas
Tomás Garzón-Muvdi, Destiny D. Bailey, Mark N. Pernik, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 41
Tomás Garzón-Muvdi, Destiny D. Bailey, Mark N. Pernik, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 41
Human Endogenous Retrovirus Type K Promotes Proliferation and Confers Sensitivity to Antiretroviral Drugs in Merlin-Negative Schwannoma and Meningioma
Emmanuel A. Maze, Bora Agit, Shona Reeves, et al.
Cancer Research (2021) Vol. 82, Iss. 2, pp. 235-247
Open Access | Times Cited: 22
Emmanuel A. Maze, Bora Agit, Shona Reeves, et al.
Cancer Research (2021) Vol. 82, Iss. 2, pp. 235-247
Open Access | Times Cited: 22
Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas
Agbolahan Sofela, David A. Hilton, Sylwia Ammoun, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 560-560
Open Access | Times Cited: 18
Agbolahan Sofela, David A. Hilton, Sylwia Ammoun, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 560-560
Open Access | Times Cited: 18
Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status
Shirin Karimi, Sheila Mansouri, Farshad Nassiri, et al.
Journal of Neuro-Oncology (2021) Vol. 151, Iss. 3, pp. 443-449
Open Access | Times Cited: 18
Shirin Karimi, Sheila Mansouri, Farshad Nassiri, et al.
Journal of Neuro-Oncology (2021) Vol. 151, Iss. 3, pp. 443-449
Open Access | Times Cited: 18
miR-497 and 219 in blood aid meningioma classification
Ahmed I. Abdelrahman, Caterina Negroni, Felix Sahm, et al.
Journal of Neuro-Oncology (2022) Vol. 160, Iss. 1, pp. 137-147
Closed Access | Times Cited: 13
Ahmed I. Abdelrahman, Caterina Negroni, Felix Sahm, et al.
Journal of Neuro-Oncology (2022) Vol. 160, Iss. 1, pp. 137-147
Closed Access | Times Cited: 13
The Molecular and Immunological Landscape of Meningiomas
Catharina Lotsch, Rolf Warta, Christel Herold‐Mende
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9631-9631
Open Access | Times Cited: 2
Catharina Lotsch, Rolf Warta, Christel Herold‐Mende
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9631-9631
Open Access | Times Cited: 2
Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas
Jacky T. Yeung, Vesal Yaghoobi, Thazin Nwe Aung, et al.
Journal of Neuropathology & Experimental Neurology (2021) Vol. 80, Iss. 2, pp. 150-159
Open Access | Times Cited: 14
Jacky T. Yeung, Vesal Yaghoobi, Thazin Nwe Aung, et al.
Journal of Neuropathology & Experimental Neurology (2021) Vol. 80, Iss. 2, pp. 150-159
Open Access | Times Cited: 14
Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review
Nivedha Kannapadi, Pavan P. Shah, Dimitrios Mathios, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Nivedha Kannapadi, Pavan P. Shah, Dimitrios Mathios, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Inflammatory Tumor Microenvironment in Cranial Meningiomas: Clinical Implications and Intraindividual Reproducibility
Johannes Wach, Tim Lampmann, Ági Güresir, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 853-853
Open Access | Times Cited: 3
Johannes Wach, Tim Lampmann, Ági Güresir, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 853-853
Open Access | Times Cited: 3
Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours
Foram Dave, Kevin Herrera, Alex Lockley, et al.
Oncogene (2024) Vol. 43, Iss. 41, pp. 3049-3061
Open Access
Foram Dave, Kevin Herrera, Alex Lockley, et al.
Oncogene (2024) Vol. 43, Iss. 41, pp. 3049-3061
Open Access
Tumor-Associated Macrophages in Meningiomas: An Independent Prognostic Factor for Poor Survival Outperforming the Benefits of T cells
Catharina Lotsch, Fang Liu, Rolf Warta, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Catharina Lotsch, Fang Liu, Rolf Warta, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A Comprehensive Framework for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: Analyzing Novel Risk Factors and Advances in Nanotechnology-Based Treatments and Diagnosis
Lucia M. Chávez-López, Gabriela I. Carballo-López, Karina del Carmen Lugo-Ibarra, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2622-2642
Closed Access
Lucia M. Chávez-López, Gabriela I. Carballo-López, Karina del Carmen Lugo-Ibarra, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2622-2642
Closed Access
Current immunotherapy techniques in meningioma
Alexandra J. White, Maya Harary, Joshua Casaos, et al.
Expert Review of Anticancer Therapy (2024), pp. 1-11
Open Access
Alexandra J. White, Maya Harary, Joshua Casaos, et al.
Expert Review of Anticancer Therapy (2024), pp. 1-11
Open Access
